Literature DB >> 14770004

An efficient system for cap- and poly(A)-dependent translation in vitro.

Yuri V Svitkin1, Nahum Sonenberg.   

Abstract

The 3' poly(A) tail of eukaryotic messenger RNAs (mRNAs) acts synergistically with the 5' cap structure to enhance translation. This phenomenon has been explained by the simultaneous binding of poly(A)-binding protein (PABP) and a cap-binding protein (eIF4E) to eIF4G that results in the circularization of the mRNA (closed-loop model). We developed a robust cell-free protein synthesis system to study poly(A)-dependent translation. In nuclease-treated extracts of Krebs-2 ascites cells, the mRNA poly(A) tail and the cap structure synergistically stimulate translation. We also describe an efficient procedure for depleting PABP from translation extracts. Greater than 98% of PABP can be depleted from extracts by preincubation with either of the PABP-interacting proteins (Paip2 or Paip1) coupled to beads, and these depleted extracts fail to support efficient translation of poly(A)+ mRNAs. Translation activity is restored to depleted extracts by the addition of recombinant PABP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770004     DOI: 10.1385/1-59259-750-5:155

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  44 in total

1.  The Apc5 subunit of the anaphase-promoting complex/cyclosome interacts with poly(A) binding protein and represses internal ribosome entry site-mediated translation.

Authors:  Nadejda Koloteva-Levine; Dalia Pinchasi; Idan Pereman; Amit Zur; Michael Brandeis; Orna Elroy-Stein
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 2.  Further evidence that ribavirin interacts with eIF4E.

Authors:  Alex Kentsis; Laurent Volpon; Ivan Topisirovic; Clifford E Soll; Biljana Culjkovic; Ling Shao; Katherine L B Borden
Journal:  RNA       Date:  2005-10-26       Impact factor: 4.942

3.  General RNA-binding proteins have a function in poly(A)-binding protein-dependent translation.

Authors:  Yuri V Svitkin; Valentina M Evdokimova; Ann Brasey; Tatyana V Pestova; Daniel Fantus; Akiko Yanagiya; Hiroaki Imataka; Maxim A Skabkin; Lev P Ovchinnikov; William C Merrick; Nahum Sonenberg
Journal:  EMBO J       Date:  2008-12-11       Impact factor: 11.598

4.  An efficient factor-depleted mammalian in vitro translation system.

Authors:  Aurélie M Rakotondrafara; Matthias W Hentze
Journal:  Nat Protoc       Date:  2011-04-07       Impact factor: 13.491

5.  Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap.

Authors:  Yifei Yan; Yuri Svitkin; Joseph M Lee; Martin Bisaillon; Jerry Pelletier
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

6.  La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro.

Authors:  Mauro Costa-Mattioli; Yuri Svitkin; Nahum Sonenberg
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Time-dependent increase in ribosome processivity.

Authors:  Jennifer M Bonderoff; Richard E Lloyd
Journal:  Nucleic Acids Res       Date:  2010-06-22       Impact factor: 16.971

8.  DCB-3503, a tylophorine analog, inhibits protein synthesis through a novel mechanism.

Authors:  Ying Wang; Wenli Gao; Yuri V Svitkin; Annie Pei-Chun Chen; Yung-Chi Cheng
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

9.  Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation.

Authors:  Marc R Fabian; Géraldine Mathonnet; Thomas Sundermeier; Hansruedi Mathys; Jakob T Zipprich; Yuri V Svitkin; Fabiola Rivas; Martin Jinek; James Wohlschlegel; Jennifer A Doudna; Chyi-Ying A Chen; Ann-Bin Shyu; John R Yates; Gregory J Hannon; Witold Filipowicz; Thomas F Duchaine; Nahum Sonenberg
Journal:  Mol Cell       Date:  2009-08-27       Impact factor: 17.970

10.  HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage.

Authors:  Alfredo Castelló; David Franco; Pablo Moral-López; Juan J Berlanga; Enrique Alvarez; Eckard Wimmer; Luis Carrasco
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.